Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 10:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1969–1992 of 2,478 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Tissue Control Group Clear all

Conditions: Sleep Apnea, Obstructive
Interventions: Desipramine, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 60 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Morbid Obesity
Interventions: propofol; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pregnancy Prevention
Interventions: Levonorgestrel 1.5mg, Meloxicam 15 mg, Placebo; Drug · Other
Lead sponsor: InnovaGyn, Inc.; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Raleigh, North Carolina

Conditions: Barrett Esophagus, Esophageal Adenocarcinoma, Barretts Esophagus With Dysplasia, Barrett's Esophagus Without Dysplasia
Interventions: EsoGuard (lab assay), Esophagogastroduodenoscopy; Device · Diagnostic Test
Lead sponsor: Lucid Diagnostics, Inc.; Industry
Eligibility: 50 Years and older · Male only
Enrollment: 784 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 29
States / cities: Aurora, Colorado • Englewood, Colorado • Washington D.C., District of Columbia + 24 more

Conditions: Atrial Fibrillation, Venous Thromboembolism, Heart Valve Diseases
Interventions: Patient self-management, Usual care provided by anticoagulation providers; Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 4
States / cities: Loma Linda, California • Boston, Massachusetts • Ann Arbor, Michigan + 1 more

Conditions: Dermatomyositis
Interventions: IMO-8400 Dose Group 1, IMO-8400 Dose Group 2, Placebo; Drug
Lead sponsor: Idera Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 17
States / cities: Birmingham, Alabama • Phoenix, Arizona • Irvine, California + 14 more

Conditions: Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus
Interventions: Matrix-M1 Adjuvant, EBV gp350-Ferritin Vaccine, Placebo Comparator; Drug · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 25 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Bethesda, Maryland • Minneapolis, Minnesota

Conditions: Wounds, Leg Ulcers, Pressure Ulcers, Diabetic Foot Ulcers
Interventions: AutoloGel System; Device
Lead sponsor: Cytomedix; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Augusta, Georgia • El Paso, Texas

Conditions: Acute Ischemic Stroke
Interventions: Transcranial ultrasound as an adjunctive therapy to tPA, Standard of care tPA therapy for acute ischemic stroke; Device · Drug
Lead sponsor: Cerevast Therapeutics, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 675 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Redmond, Washington

Conditions: Rib Fractures
Interventions: Cryoneurolysis of Intercostal Nerves, Standard of Care; Device · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Ovarian Suppression
Interventions: Low dose formulation, High dose formulation; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 226 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Opioid Abuse, Opioid Misuse, Pain
Interventions: Oxycodone; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: educational intervention; Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years to 120 Years
Enrollment: 583 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 4
States / cities: Detroit, Michigan • Cleveland, Ohio • Philadelphia, Pennsylvania

Conditions: Type 1 Diabetes, Diabetes Mellitus, Type 1
Interventions: CELZ-201 Administration, Control Group; Biological · Other
Lead sponsor: Creative Medical Technology Holdings Inc; Industry
Eligibility: 18 Years to 35 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Lymphedema, Edema
Interventions: BioBridge® Collagen Matrix, Vascularized Lymph Node Transfer (VLNT); Device · Procedure
Lead sponsor: Fibralign Corporation; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 2
States / cities: Chicago, Illinois • Houston, Texas

Conditions: Obesity, Overweight, Overweight and Obesity, PreDiabetes, Type 2 Diabetes, Type 2 Diabetes Mellitus, Type 2 Diabetes Mellitus in Obese
Interventions: Physical Activity Intervention; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 30 Years to 64 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Brain Injuries, Craniocerebral Trauma
Interventions: Not listed
Lead sponsor: BrainScope Company, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 816 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 11
States / cities: Hartford, Connecticut • Baltimore, Maryland • Detroit, Michigan + 6 more

Conditions: Urinary Retention
Interventions: Peppermint Oil Vapor, Mineral Oil Vapor; Other
Lead sponsor: Mount Carmel Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Adipose Tissue Atrophy
Interventions: Venus Bliss; Device
Lead sponsor: Venus Concept; Industry
Eligibility: 21 Years to 60 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 2
States / cities: Beverly Hills, California • Dallas, Texas

Conditions: Urinary Stress Incontinence
Interventions: Artificial Urinary Sphincter Placement; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Male only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Breast Cancer, BRCA Mutation
Interventions: Tranexamic acid, Normal saline; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 80 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Substance Use Disorders, Opiate Dependence, Opiate Withdrawal Syndrome, Opioid-use Disorder, Alcohol Withdrawal, Alcohol Abuse, Alcohol Use Disorder, Cocaine Abuse, Cocaine Use Disorder, Cocaine Withdrawal, Benzodiazepine Abuse, Benzodiazepine Dependence, Substance Abuse, Heroin Overdoses, Heroin Withdrawal, Heroin Abuse
Interventions: Six Step Model of Self-Forgiveness, Treatment as Usual (TAU); Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: McKeesport, Pennsylvania

Conditions: Gingival Recession
Interventions: Puros® Dermis versus Alloderm®; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 4
States / cities: Birmingham, Alabama • Ann Arbor, Michigan • Newark, New Jersey + 1 more

Conditions: Hypertension, End Stage Renal Disease
Interventions: Vasopressin - Very Low Dose, Vasopressin - Low Dose, Placebo Comparator; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Effect of Desipramine on Genioglossus Muscle Activity in Healthy Adults Study A

A High Resolution Pharmacokinetic/Pharmacodynamic Model of Propofol in Morbidly Obese Subjects

Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days

Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC

Warfarin Patient Self-management Implementation in the US Healthcare System

Trial of IMO-8400 in Adult Patients With Dermatomyositis

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

The AutoloGel™ Post-Market Surveillance (TAPS) Program

Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke

Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis

Obesity, Oral Contraception, and Ovarian Suppression

Opioid Reduction Toolkit Reduces Opioids Prescribed and Consumed

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes

LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)

The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults

Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology

Postpartum Urinary Retention With Essential Oils (PURE)

Analysis of the Performance of 1060 nm Diode and Radio Frequency Prior to Abdominoplasty

Transcorporal Versus Standard Artificial Urinary Sphincter Placement

Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage

The Effect of Self-Forgiveness on Self-Stigma in Addiction.

Study of Root Coverage With Acellular Dermal Matrix: Puros® Dermis Versus Alloderm®

Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease